Want to see SG:5WV full AI Analyst Report?
Top Page
AsiaPhos Limited
(SGX:5WV)
Select Model
Select Model
Rating:46Neutral
Price Target:
S$0.01
▲(0.00% Upside)
Action:Reiterated
Date:07/01/26
The score is held down primarily by weak financial performance—especially recurring cash burn and loss-making operations alongside a sharp 2025 revenue decline and margin compression. Neutral technicals (flat vs. short-term moving averages) provide limited offset, while valuation offers little support because the company is currently loss-making (negative P/E) and has no dividend yield data.
Positive Factors
Revenue Growth
Strong revenue growth indicates robust demand for AsiaPhos's products and suggests successful market penetration, supporting long-term business expansion.
Negative Factors
Profitability Challenges
Negative margins indicate operational inefficiencies that could hinder long-term financial health unless addressed, impacting overall profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Strong revenue growth indicates robust demand for AsiaPhos's products and suggests successful market penetration, supporting long-term business expansion.
Read all positive factors
AsiaPhos Limited (5WV) vs. iShares MSCI Singapore ETF (EWS)
Market Cap
S$13.32M
Dividend YieldN/A
Average Volume (3M)5.83M
Price to Earnings (P/E)―
Beta (1Y)-0.33
Revenue GrowthN/A
EPS GrowthN/A
CountrySG
Employees49
SectorBasic Materials
Sector Strength58
IndustryIndustrial Materials
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,479,627,200
10 Day Avg. Volume10,042,989
30 Day Avg. Volume5,825,116
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)7.87
Price to Sales (P/S)2.51
P/FCF Ratio-36.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AsiaPhos Limited Business Overview & Revenue Model
Company Description
AsiaPhos Limited, a Singapore-headquartered investment holding company established in 1996, primarily focuses on the manufacturing and global distribution of phosphate-based chemical products. Its operations are structured into two distinct divisi...
AsiaPhos Limited Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
52
Neutral
Cash Flow
24
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.32M | 4.29M | 1.70M | 2.42M | 1.57M |
| Gross Profit | 360.00K | 367.00K | 328.00K | 500.00K | 215.00K |
| EBITDA | -1.31M | -2.28M | -3.68M | -822.00K | -3.50M |
| Net Income | -1.69M | 1.17M | 2.07M | -1.56M | -65.97M |
Balance Sheet | |||||
| Total Assets | 2.54M | 4.59M | 21.05M | 17.78M | 21.85M |
| Cash, Cash Equivalents and Short-Term Investments | 1.02M | 1.43M | 865.00K | 757.00K | 2.88M |
| Total Debt | 128.00K | 159.00K | 3.06M | 5.97M | 8.59M |
| Total Liabilities | 898.00K | 1.17M | 21.25M | 19.30M | 20.99M |
| Stockholders Equity | 1.69M | 3.38M | 2.33M | 1.01M | 3.40M |
Cash Flow | |||||
| Free Cash Flow | -369.00K | -4.87M | -5.00K | -3.29M | -2.69M |
| Operating Cash Flow | -369.00K | -4.84M | 170.00K | -3.26M | -2.68M |
| Investing Cash Flow | 0.00 | 9.60M | -175.00K | 1.84M | 4.39M |
| Financing Cash Flow | -31.00K | -3.78M | 167.00K | -437.00K | 256.00K |
AsiaPhos Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | S$664.79M | 8.30 | 9.20% | 4.40% | -8.74% | -6.08% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | S$44.05M | -3.92 | -19.55% | 0.92% | -7.25% | 95.72% | |
46 Neutral | S$13.32M | -7.50 | ― | ― | ― | ― | |
44 Neutral | S$41.76M | -0.92 | -33.12% | ― | -54.41% | -10.14% |
* Basic Materials Sector Average
SG:5WV
AsiaPhos Limited
0.01
0.00
0.00%
SG:QES
China Sunsine Chemical Holdings Ltd.
0.68
0.10
17.85%
SG:C05
Chemical Industries Far East Ltd.
0.56
0.08
16.67%
SG:5DS
MegaChem Ltd.
0.49
0.10
25.32%
SG:C8R
Jiutian Chemical Group Limited
0.02
>-0.01
-22.22%
SG:Y8E
Samurai 2K Aerosol Ltd.
0.13
0.04
44.44%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.